SCHEMBL26337409

SCHEMBL26337409

CCC(=O)O[C@@H](c1ccc2c(N)ncnn12)[C@H](OC(=O)CC)[C@@](C)(CO[PH](=O)N[C@@H](C)C(=O)OCC1CCOCC1)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26332594 0.85 — —
SCHEMBL26332563 0.84 RIPK1 (0.31) —
SCHEMBL23818680 0.83 — —
SCHEMBL23819015 0.82 — —
SCHEMBL23819292 0.80 — —
SCHEMBL23819020 0.80 RIPK1 (0.31) —
SCHEMBL23818648 0.79 BTN3A1 (0.35) —
SCHEMBL23819033 0.77 — —
SCHEMBL23819047 0.77 — —
SCHEMBL23819242 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767337-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2023-09-26 — — US disclosed
Send feedback